Ignite Creation Date:
2024-07-17 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06462794
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-06-12
Brief Title:
First In Human Study of CX-801 in Advanced Solid Tumors
Sponsor:
CytomX Therapeutics
Organization:
CytomX Therapeutics
Organization Data
Organization:
CytomX Therapeutics
Class:
INDUSTRY
Study ID:
CTMX-801-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CytomX Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |